(VIANEWS) – The NASDAQ ended the session with Catalyst Pharmaceuticals jumping 5.58% to $5.30 on Thursday, after four successive sessions in a row of gains. NASDAQ Composite dropped 0.44% to $14,448.58, after five consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.


Today’s last reported volume for Catalyst Pharmaceuticals is 3365640, 332.33% above its average volume of 778479.

Catalyst Pharmaceuticals’s last close was $5.08, 18.59% under its 52-week high of $6.24.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the current quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $5.30 at 17:18 EST, way below its 52-week high of $6.24 and way above its 52-week low of $2.88.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is under its 50-day moving average of $5.32 and higher than its 200-day moving average of $5.23.

More news about Catalyst Pharmaceuticals (CPRX).


Please enter your comment!
Please enter your name here